Effects of COVID-19 pandemic on the management of pulmonary hypertension

The coronavirus of 2019 (COVID-19) disrupted delivery of healthcare. Patients with pulmonary hypertension (PH), especially pulmonary arterial hypertension (PAH), require significant resources for both diagnosis and management and are at high risk for decompensation due to disruption in their care. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Christine Y., Sahay, Sandeep, Shlobin, Oksana, Soto, Francisco J., Mathai, Stephen C., Melendres-Groves, Lana, Mullin, Christopher J., Levine, Deborah J., Kay, Dana, Highland, Kristin, Bossone, Eduardo, Poms, Abby, Memon, Humna, Balasubramanian, Vijay, Farmer, Mary Jo S., Rahaghi, Franck, Elwing, Jean M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699715/
https://www.ncbi.nlm.nih.gov/pubmed/36493604
http://dx.doi.org/10.1016/j.rmed.2022.107061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699715/
https://www.ncbi.nlm.nih.gov/pubmed/36493604
http://dx.doi.org/10.1016/j.rmed.2022.107061

Ejemplares similares